MedPath

Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1

Phase 1
Conditions
Cocaine-Related Disorders
Registration Number
NCT00040066
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.

Detailed Description

The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Cocaine dependent, non treatment seeking individuals
Exclusion Criteria

Please contact site directly for details.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cocaine related high
Cocaine craving
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University of Texas Health Science Center

🇺🇸

San Antonio, Texas, United States

UCLA Integrated Substance Abuse Program

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath